Overview
Melstacorp is a diversified Sri Lankan holding company with major beverage, consumer, tourism, logistics, plantation, financial-services and strategic-investment interests, including several listed subsidiaries. The latest quarter showed a mixed operating picture: revenue expanded and net profit rose, but core operating profit contracted as margins narrowed. The longer audited record is firmer, with higher annual profit, lower borrowings and rising owners' equity.
Price performance
MELS closed at LKR 180 on 9 October 2026. It fell 3.2% over one month against a 4.9% ASPI decline, while its 6.5% one-year gain contrasts with a 6.3% fall in the index; the share has therefore outperformed the market over those windows without avoiding recent weakness.
The price sits 58.1% through its 52-week range, 6.7% below its high and 11.1% above its low. Sixty-day volatility was 35.0% below its own one-year level and recent volume was 80.2% below its 60-day norm, indicating quieter trading rather than an unusually active market in the shares.
The three-year record contains two falls of 15% or more, the deepest 20%, which took seven months to recover. Median daily turnover was LKR 2.4 million: a LKR 1 million order is about 41% of what trades on a typical day, a large part of a day's trading.
Valuation
At 10.4 times earnings, the shares ask for LKR 10.40 for each LKR 1 of trailing profit, versus a 14.51 times sector median. The P/E is at the 31st percentile of reporting diversified-holdings peers, while the 4.5% dividend yield is at the 69th percentile. The payout has risen from LKR 7.32 in FY2025 to LKR 8.15 in FY2026, although the most recent year may not yet be complete.
P/B is 1.26 times, meaning LKR 1.26 for each LKR 1 of net assets, close to the sector median of 1.21 times. This is more expensive than 83% of days since December 2016, whereas the P/E is more expensive than 54% of days over that record. The contrast says the shares are relatively inexpensive on current earnings but not on their own book-value history; a 12.1% return on equity helps explain why P/B sits above the sector median.
The latest June quarter supplied 26.6% of trailing EPS. Its 8.6% net margin was slightly below the year-ago 8.9%, but using that earlier margin would leave the present P/E at 10.3 times, so the trailing multiple does not depend heavily on a one-quarter margin uplift.
News and sentiment
Direct coverage was normal but unusually quiet in the last 30 days, with no material articles against a monthly baseline of 2.5. Across 90 days, 12 of 25 material articles were negative, 8 positive and 5 neutral, a split largely shaped by transaction and trading-halt coverage rather than reported operating results.
The most consequential development was the proposed sale of Continental Insurance Lanka, reported on 13 and 14 August. The agreed consideration exceeds LKR 5.14 billion for 100%, beginning with 81% and with the balance in later tranches, subject to IRCSL approval and conditional adjustments. Relative to Melstacorp's LKR 286.0 billion audited annual revenue, the consideration is small as a sales-equivalent measure, but the data does not disclose the insurance unit's profit contribution, so the earnings effect cannot be sized. BMW importer and distributor status for Mels Automobiles was reported on 5 May, but no financial terms were disclosed.
The LKR 3.25 third interim dividend went ex-dividend on 8 July 2026, so a buyer at the current price does not receive it.
Financials
In the June 2026 quarter, revenue rose 7.9% year-on-year but operating profit fell 14.8%, while net profit still rose 4.4% to LKR 5.8 billion. Gross margin was 25.2% versus 29.0% a year earlier, operating margin 12.3% versus 15.6%, and net margin 8.6% versus 8.9%. The lower operating margin means the business retained less from each rupee of sales; a smaller LKR 2.5 billion gap between operating and net profit, versus LKR 4.2 billion a year earlier, helped preserve net-profit growth.
June's gross and operating margins ranked middling at 5 of the last 7 comparable June quarters, while net margin ranked 3 of 7. The result is therefore weaker than last year but not an unusually poor June on the company's own like-for-like record.
For the audited year to March 2026, revenue grew 9.6% and net profit rose 17.9%, with annual net margin at 9.2%. Equity attributable to owners reached LKR 157.1 billion, and the balance-sheet share count was unchanged at 1.17 billion ordinary shares, so the improvement was not mechanically created by a larger ordinary share base. Minority shareholders received 25.0% of group profit, meaning group net profit is materially larger than the profit attributable to the ordinary shares being valued.
Risks
The foremost risk is pressure on operating profitability. June operating profit fell despite higher revenue, and the 12.3% operating margin was below the prior year's 15.6%; further deterioration would reduce the earnings base supporting the current P/E.
Funding risk is moderate rather than absent. At March 2026, gearing was 28.2%, meaning debt equalled 28 cents for every rupee of equity attributable to owners, and interest cover was 5.96 times, meaning operating profit covered the interest bill almost six times. The current ratio was 1.23, so short-term assets, including inventory and customer receivables, exceeded bills due within a year, but not by a wide margin. Cash conversion was 0.71 times, so only 71 cents of operating cash flow arrived for each rupee of operating profit in the audited year; the profit improvement was not fully cash-backed.
Consumer retail represents 71.7% of reported segment revenue, making cost-conscious household spending the more relevant backdrop risk. Tourism represents the remaining 28.3%, where year-to-date visitor arrivals were behind the prior year as at the October sector update. The Continental Insurance sale also remains subject to regulatory approval, and its staged structure means the full disposal is not an immediate completed exit.
Outlook
As at 12 October 2026, the next material company-specific event is the September 2026 interim filing, expected between 6 and 14 November. It will replace the June-quarter evidence and show whether the operating-margin contraction persisted or was confined to that period.
The other key disclosed development is the Continental Insurance transaction, whose approval and later completion terms will determine when Melstacorp ceases to own the business and what capital it receives. The available data does not disclose Continental Insurance's profit contribution or Melstacorp's intended use of proceeds, so it cannot establish the disposal's eventual effect on group earnings.